Veja os assuntos que mais chamaram a atenção dos leitores do Portal 2A+ Farma. Leia Mais »
Arquivo Diário: 10/06/2022
Cold Chain Technologies Announces Regional Manufacturing of CCT Thermal Covers in Montevideo (Uruguay)
FRANKLIN, Mass., June 10, 2022 — Cold Chain Technologies, LLC (“CCT” or “Company”), a leading global provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, announced its further expansion into Latin America with the opening of a new manufacturing facility for the production of CCT Thermal Covers, powered by Tyvek®, in Montevideo (Uruguay).
The new regional manufacturing site, which is expected to start operations by September 2022, will enhance service for customers in the life sciences industry by manufacturing CCT Thermal Covers locally. Latin America is a key growth market for CCT as it continues expansion worldwide. With more than 50 years of ensuring product safety in transit, CCT has built a reputation as the industry’s most innovative and reliable provider to the largest global life sciences companies and distributors.
“By being global and acting local, we ensure that we are providing best-in-class services and products while enhancing our operational capabilities within the Latin American region to support the needs of our clients,” said Vanessa Burri, CCT Regional Sales Director for Latin America.
Kristof De Smedt, Global Business Unit Director for the CCT Thermal Covers Business Unit, stated, “We are extremely proud to further expand our global manufacturing network with a new conversion site in Uruguay in order to provide CCT’s thermal covers throughout the entire Latin American region. CCT Thermal Covers, powered by Tyvek®, are validated in a wide variety of distribution applications worldwide to secure integrity and efficacy of temperature-sensitive healthcare and life science products, including the COVID-19 vaccine.”
As maiores feiras das indústrias farmacêutica e cosmética já têm data marcada para 2023
Atualmente a vacina Coronavac está em uso emergencial no Brasil e está autorizada para pessoas a partir dos seis anos de idade. Leia Mais »
Produto na área de gastroenterologia será fabricado em Indaiatuba Leia Mais »
A vacina candidata mRNA- 1273. 214 demonstrou um aumento de 8 vezes nas taxas de anticorpos neutralizantes contra a variante; está planejada para as próximas semanas uma submissão regulatória nos EUA que permita o uso da vacina como dose de reforço. Leia Mais »
Até 11 de junho, a Secale Orgânicos participa da Bio Brazil Fair, a principal feira do setor orgânico e apresentará os seus lançamentos Leia Mais »